Lightbown J W, Kogut M, Grab B
Bull World Health Organ. 1966;34(2):285-92.
The National Institute for Medical Research, London, was requested by the WHO Expert Committee on Biological Standardization to arrange a collaborative assay of the International Reference Preparation of Novobiocin in order to define the International Unit of Novobiocin. The collaborative assay showed that the International Reference Preparation was not suitable for use as an international standard, and a second preparation of 400 g of novobiocin acid was obtained in 1962. This second preparation was distributed into ampoules in 100-mg amounts and dried in vacuum. The ampoules were then filled with dry nitrogen and sealed. This material-the proposed international standard for novobiocin-has been assayed biologically in eight laboratories in six countries by means of plate diffusion assays; it has been assayed against the working standard preparation of the US Food and Drug Administration.The variation in the potencies obtained for the second proposed international standard for novobiocin were small and not significant. The material has been established as the International Standard for Novobiocin with a defined potency of 970 International Units per mg, and the International Unit has been defined as the activity contained in 0.001031 mg of the International Standard.
世界卫生组织生物标准化专家委员会要求伦敦的国立医学研究所安排新霉素国际参考制剂的协作测定,以确定新霉素的国际单位。协作测定表明,该国际参考制剂不适合用作国际标准,1962年获得了400克新霉素酸的第二批制剂。第二批制剂以100毫克的量分装在安瓿中,并进行真空干燥。然后向安瓿中充入干燥氮气并密封。这种材料——提议的新霉素国际标准——已在六个国家的八个实验室通过平板扩散法进行了生物学测定;已与美国食品药品监督管理局的工作标准制剂进行了测定。提议的第二批新霉素国际标准所获得的效价变化很小且不显著。该材料已被确立为新霉素国际标准,规定效价为每毫克970国际单位,国际单位被定义为0.001031毫克国际标准中所含的活性。